Related Experiment Video
Updated: May 19, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
TGFBR1 tagging SNPs and gastric cancer susceptibility: a two-stage case-control study in Chinese population
Jianjian Chen1, Lin Miao, Guangfu Jin
1Institute of Digestive Endoscopy and Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Health Promotion, Wuxi Center for Disease Prevention and Control, Wuxi, China.
Abstract:
The transforming growth factor (TGF)-β is a potent growth inhibitor primarily responsible for cell growth, differentiation, and apoptosis, and frequently perturbed during development of tumors, including gastric cancer. TGF-β receptor type I (TGFβR1) may be a modifier of cancer risk by constitutively decreasing the TGF-β inhibitory signals during early tumorigenesis and increasing the TGF-β signals in tumor progression. In this study, we hypothesized that genetic variants of TGFBR1 may influence the risk of gastric cancer. We conducted a two-stage case-control study of gastric cancer, including 650 cases and 683 controls in the first stage and 484 cases and 348 controls in the second stage, and genotyped five tagging single nucleotide polymorphisms (SNPs) to represent common variants in the whole TGFBR1 gene. In the first stage, two SNPs rs6478974 and rs10512263 were found to be potentially associated with risk of gastric cancer (P = 3.35 × 10(-3) for rs6478974 AT vs. TT and P = 0.033 for rs10512263 CT vs. TT), which were further confirmed in the second stage with similar effects (P = 0.144 and 0.049, respectively). After combining the two stages, we found that these two SNPs were associated with a significantly increased risk of gastric cancer in dominant models [adjusted odds ratio (OR) = 1.36, 95% confidence interval (CI): 1.14-1.63 for rs6478974 AT/AA vs. TT; adjusted OR = 1.26, 95% CI: 1.05-1.50 for rs10512263 CT/CC vs. TT] or additive model (adjusted OR = 1.23, 95% CI: 1.08-1.40 for rs6478974). These findings indicate that TGFBR1 polymorphisms may be implicated with the development of gastric cancer in Han-Chinese population.
Insights
Genetic variants in the transforming growth factor-beta receptor type I (TGFBR1) gene are associated with an increased risk of gastric cancer. Specific single nucleotide polymorphisms (SNPs) in TGFBR1 may influence gastric cancer development in the Han-Chinese population.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator of cell growth, differentiation, and apoptosis.
- Dysregulation of TGF-β signaling is frequently observed in various cancers, including gastric cancer.
- TGF-β receptor type I (TGFβR1) plays a critical role in mediating TGF-β signaling and may influence cancer risk.
Purpose of the Study:
- To investigate the potential association between genetic variants in the TGFBR1 gene and the risk of developing gastric cancer.
- To identify specific single nucleotide polymorphisms (SNPs) within TGFBR1 that may confer susceptibility to gastric cancer.
Main Methods:
- A two-stage case-control study was conducted, involving a total of 1134 gastric cancer cases and 1031 controls.
- Five tagging single nucleotide polymorphisms (SNPs) in the TGFBR1 gene were genotyped to represent common variants.
- Statistical analyses, including dominant and additive models, were used to assess the association between TGFBR1 SNPs and gastric cancer risk.
Main Results:
- Two SNPs, rs6478974 and rs10512263, showed a potential association with gastric cancer risk in the initial stage.
- These associations were confirmed in the second stage, with similar effect sizes.
- Combined analysis revealed that specific genotypes of rs6478974 and rs10512263 were significantly associated with an increased risk of gastric cancer (e.g., adjusted OR = 1.36 for rs6478974 in a dominant model).
Conclusions:
- Polymorphisms in the TGFBR1 gene are implicated in the development of gastric cancer.
- The identified TGFBR1 variants may serve as potential genetic modifiers of gastric cancer risk.
- Further research is warranted to elucidate the functional mechanisms underlying these associations in the Han-Chinese population.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
